![]() |
|
|
Department of Human Nutrition, Food and Animal Sciences, University of Hawaii, Honolulu, HI 96822
3To whom correspondence should be addressed. E-mail: mdunn{at}hawaii.edu
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: aluminum calbindin mRNA vitamin D intestine chicks
| INTRODUCTION |
|---|
|
|
|---|
The symptoms of aluminum toxicity include neurodegenerative disorders,
mycrocytic anemia unresponsive to iron and bone disease (vitamin
D-resistant osteomalasia). The molecular mechanisms causing
these symptoms are not well understood. Many biochemical processes have
been shown to be affected by aluminum, but there is little agreement as
to which are relevant to its toxic effects. Some proposed mechanisms
include disrupting membrane function, inducing oxidative stress,
altering G-protein function, interfering with gene expression and
disrupting mineral metabolism, especially iron, phosphate and calcium
(7
8
9)
. In this article, we extend our studies into the
effects of dietary aluminum on vitamin D-dependent
processes regulating calcium metabolism (10
,11)
. This area
may be of particular relevance to individuals with compromised vitamin
D status as occurs with damaged or immature kidneys or in the elderly.
Aluminum is known to affect at least two vitamin D target tissues,
intestine and bone, and within these tissues to inhibit the expression
of at least two vitamin D-dependent proteins involved in
calcium metabolism, calbindin and osteocalcin. In bone, the metal has
been shown to inhibit mineralization and bone formation by decreasing
both osteoblast numbers and their functional activity
(7
,12)
. Osteocalcin is an abundant bone matrix protein
secreted by osteoblasts and is widely accepted as an indicator of
osteoblast activity. The synthesis of osteocalcin is upregulated at the
transcriptional and translational levels by
1,25-dihydroxycholecalciferol
[1,25(OH)2D]4
, the active form of vitamin D, in cooperation with other regulatory
factors (13
,14)
. Cell-culture studies have shown that
aluminum inhibits 1,25(OH)2D stimulation of
osteocalcin synthesis and release from osteoblast-like osteosarcoma
cells, suggesting that aluminum inhibits osteoblast activity by
inhibiting cellular responsiveness to 1,25(OH)2D
(15
,16)
.
Aluminum toxicity has also been shown to decrease the responsiveness of
the intestine to 1,25(OH)2D. Intestinal calbindin
is a calcium-binding protein involved in the transcellular movement
of calcium across the enterocyte (17)
. Its concentration
is also thought to be regulated at both transcriptional and
posttranscriptional levels by 1,25(OH)2D, in
cooperation with other regulatory factors (18
,19)
. In both
rats and chicks, aluminum toxicity inhibits the classic ability of
injected 1,25(OH)2D to upregulate the
concentration of intestinal calbindin (11
,20)
. In a more
practical setting, we have shown that dietary aluminum also inhibits
the upregulation of intestinal calbindin when chicks are placed on a
low calcium diet (10)
. Low calcium diets are a physiologic
stimulus to increase circulating levels of
1,25(OH)2D, enhance calbindin gene expression
and, in cooperation with other vitamin D-dependent
processes, increase the efficiency of calcium absorption
(17
,21)
. Consistent with these inhibitory effects of
aluminum on intestinal calbindin levels, studies have shown that
aluminum inhibits the ability of vitamin D to increase the efficiency
of intestinal calcium absorption in experimental animals
(20
,22
23
24)
.
The evidence cited above indicates that the ability of
1,25(OH)2D to regulate the expression of
important functional proteins in target tissues is inhibited by
aluminum. The mechanism for this inhibition is not known. Fanti et al.
(16)
showed that in rat osteosarcoma cells stimulated with
1,25(OH)2D, osteocalcin mRNA levels were not
affected by aluminum, nor were rates of osteocalcin degradation. These
findings led to the conclusion that aluminum inhibits osteocalcin
synthesis at a posttranscriptional step. No similar studies have been
conduced on the regulation of intestinal calbindin.
The purpose of the present study is to determine whether dietary aluminum intake inhibits the expression of calbindin mRNA in the intestine. In particular, we wanted to determine whether aluminum inhibits the increase in intestinal calbindin levels in chicks fed low calcium diets, by preventing the 1,25(OH)2-dependent increase in calbindin mRNA. To test this hypothesis, groups of chicks were fed control and low calcium diets, with and without added aluminum. Intestinal calbindin and calbindin mRNA were measured by immunoblotting and a nonradioactive oligonucleotide-based hybridization assay, respectively.
| MATERIALS AND METHODS |
|---|
|
|
|---|
One-day-old White Leghorn cockerels (Asagi Hatchery, Honolulu, HI.) were assigned to five pens of 15 birds each so that mean body weight within pens was similar (35 ± 1 g). Chicks were housed in a stainless steel brooder in a room free of sunlight with a 12-h light:dark cycle. Four pens of chicks were fed a control diet for 1 wk. For the following 2 wk, one of the pens was maintained on the control diet, and three were switched to one of the following diets: low calcium, low calcium plus aluminum or the control diet plus aluminum. The fifth pen was fed a vitamin D-free diet from d 1 as a negative control. All chicks had free access to the diets and deionized water.
The composition of the experimental diets is shown in Table 1
. All diets were mixed in our laboratory. The control diet composition
was based on the reference soy isolate diet for chicks defined by the
National Research Council (25)
. Aluminum was added in the
form of AlCl3-6H2O to a
final concentration of 0.3 g of aluminum/100 g diet. Mineral
content of the diets was verified by analysis as described previously
(11)
. The experimental protocol was approved by the
University of Hawaii Animal Care Advisory Committee.
|
After 3 wk, individual body weights and feed consumption per pen were measured. Chicks were euthanized by CO2 asphyxiation and 10 cm of duodenum just distal to the gizzard was immediately excised and flushed with ice-cold saline. The intestinal segment was slit open and divided in two, lengthwise. One half was immediately frozen in liquid nitrogen and held at -80°C until pooled (see below) for mRNA extraction. The other half was scraped with a glass slide to collect the mucosal layer, which, after pooling (see below), was frozen in liquid nitrogen and stored at -80°C until used for protein extraction. Within a dietary treatment, samples of intestine or mucosal scrapings from three chicks were pooled, resulting in five samples for extraction of calbindin mRNA or protein, respectively.
Blood samples were obtained by heart puncture after excision of the intestine. Stainless steel needles and vacutainers without additives were used for collection. After allowing the blood to clot for 3060 min, the vacutainers were centrifuged for 10 min at 2000 x g. Serum was transferred to microfuge tubes and stored at -20°C until analysis.
Analysis of serum calcium and phosphorous.
For calcium analysis, serum samples were diluted 1:20 with 120 mmol/L HCl (trace metal grade). The diluted serum was analyzed via inductively coupled plasma emission spectroscopy (model 6500; Perkin Elmer, Norwalk, CT). A sample of deionized water, passed through the same handling procedures and containers as the serum, was used as a blank. Serum inorganic phosphorus was analyzed using a commercial kit based on the ultraviolet absorbance of a phosphomolybdate complex (Sigma, St. Louis, MO).
Calbindin extraction and immunoblotting.
Pooled samples of mucosal scrapings (
0.5 g) were homogenized
(Polytron; Brinkman Instruments, Westbury, NY) in two volumes of cold
homogenization buffer (10 mmol/L Tris, 1.5 mmol/L ethylene
glyco-bis(ß-aminoethyl ester)-N,N,N',N'-tetraacetic
acid, 120 mmol/L NaCl, 1 mmol/L phenylmethysulfonyl fluoride, 1 mg/L
aprotinin). The homogenate was centrifuged at 18,000 x g for 20 min at 4°C. The supernatant was heated at
60°C for 5 min, cooled on ice and centrifuged as above. Protein
concentration of the heat-stable supernatants was determined
(Bio-Rad Protein Assay, Richmond, CA) and they were stored at -80°C
until used for the assay of calbindin by slot immunoblots, and for
verification of calbindin antibody specificity by Western
immunoblotting.
For Western immunoblotting, 20-µg samples of heat-stable supernatant protein were subjected to discontinuous sodium dodecyl sulfate-polyacrylamide gel electrophoresis on 13% T separating gels using standard procedures (Hoefer Scientific Instruments, San Francisco, CA). Molecular weights were estimated by comparison to low-molecular-weight protein standards (Bio-Rad Laboratories, Hercules, CA). Duplicate gels were run, one was stained in Coomassie Blue R-250 for screening of protein quantity and quality, and the other was processed for protein transfer to nitrocellulose membranes. For protein transfer, gels were equilibrated in transfer buffer (25 mmol/L Tris, 192 mmol/L-glycine, 20% methanol, pH 8.5) and electroblotted for 40 min at 0.5 Amp. After transfer, the nitrocellulose was rinsed in deionized water, air dried, and stored at 4°C until developed by immunodetection of calbindin-D28k.
For slot immunoblots, 1.5 µg of heat-stable supernatant protein was diluted in 100 µL of homogenization buffer and applied to nylon membranes using a slot-blot apparatus following manufacturers procedures (Bio-Rad Laboratories). The membrane was air dried and stored at 4°C until immunodevelopment.
For immunodevelopment, the membrane from either the Western or slot-blot was equilibrated in Tris-buffered saline [TBS (20 mmol/L Tris, 500 mmol/L NaCl, pH 7.5)], then blocked in 10 g/L bovine serum albumin in TBS for 0.5 h. After blocking, the membrane was washed in TBS plus 0.05% Tween 20 (TTBS) and incubated for 2 h with monoclonal anticalbindin-D28k (Sigma) diluted 1:1000 in TTBS. The membrane was then rinsed in TTBS and incubated for 1 h with anti-mouse immunoglobulin G-alkaline phosphatase conjugate (Sigma) diluted 1:30,000 in TTBS. The membrane was then washed twice in TTBS and once in TBS, followed by color development using standard procedures (Sigma Fast alkaline phosphatase substrate tablets; Sigma).
Northern and slot-blot analysis of calbindin mRNA.
mRNA was extracted directly from pooled intestinal tissue (
1 g)
using an oligo-dT-cellulose-based commercial kit (PolyAPure; Ambion,
Austin, TX). Absorbance at 260 nm was used to determine the
concentration of mRNA. The mRNA (5 µg) was denatured in formaldehyde
and formamide and size-fractionated by electrophoresis in 1%
agarose:1.5% formaldehyde gels following standard procedures (Life
Technologies, Rockville, MD). The samples were size-fractionated
with ethidium bromide added (0.05 µg/µL) to allow visual comparison
of mRNA quantity and integrity, and size comparison to RNA molecular
weight markers (Life Technologies). All mRNA was screened in this way
before slot-blot analysis (described below). Northern analysis was
performed on a random sample from both the control and vitamin
D-free groups to verify the specificity of the calbindin
hybridization probe (see Results). Samples used for Northern analysis
had no ethidium bromide added during electrophoresis. For Northern
transfer, excess formaldehyde was rinsed out of the gel with water, and
the mRNA was blotted onto a nylon membrane (Tropilon Plus; Chemicon,
Temecula, CA) via capillary transfer overnight in 20 x standard
saline citrate [SSC (3 mol/L NaCl, 0.3 mol/L sodium citrate, pH
7.0)]. After transfer, the membrane was rinsed in 2 x SSC,
air-dried, and ultraviolet cross-linked at 120
mJ/cm2 (GS Gene Linker; Bio-Rad Laboratories).
For slot-blots, mRNA was denatured in formaldehyde and formamide, diluted in 10 x SSC, and applied to a nylon membrane using a slot-blot device following recommended procedures (Bio-Rad Laboratories). Each mRNA sample was applied twice, 1 µg was applied on one half of the membrane for analysis of calbindin mRNA, and 0.5 µg was applied on the other half for analysis of B-actin mRNA. These amounts were determined in pilot experiments to fall within the linear range of the hybridization assays for the respective mRNA. After sample application, the membrane was air-dried and ultraviolet cross-linked at 120 mJ/cm2 (GS Gene Linker; Bio-Rad Laboratories).
Membranes from both the Northern and slot-blots were prehybridized,
hybridized and washed under the same conditions. The hybridization
probes for calbindin-D28k and B-actin mRNA were synthetic
oligonulceotides double-end-labeled with fluorescein isothiocyanate
(FITC) purchased from Biognostik (Gottingen, Germany). The
calbindin probe (5'-ATT TTC CTC AGC ACA GAG AAT GAG AGC CAG TTC TGC TCG
GTA-3') was complementary to 42 bases of the chicken intestinal
calbindin-D28k message coding for amino acids 249262 at the
carboxy-terminus (26)
. A ß-actin
probe complementary to bases 10921120 of the human sequence (100%
homologus to chicken B-actin) was used as a control probe. Membranes
were prehybridized for 3 h at 3033°C in hybridization buffer
(3 mol/L NaCl, 200 mmol/L NaH2PO4, 20 mmol/L
EDTA, pH 7.4, 5 x Denhardts solution, 5 g/L sodium dodecyl
sulfate, 0.1 g/L denatured herring sperm DNA, 50% formamide). The
slot-blot membrane was cut in half for separate calbindin and
ß-actin hybridizations. Hybridizations were performed overnight at
3033°C in hybridization buffer containing either 10 nmol/L of
heat-denatured calbindin-D28k probe or 21 nmol/L
ß-actin probe. After hybridization, the membranes were
washed for 30 s in 2 x SSC, followed by two more washes for
15 min each at room temperature, and two stringent washes in 0.8
x SSC for 15 min each at 40°C. The chemiluminescent detection
of hybridized FITC-labeled probe was carried out using a commercial
anti-FITC immunodetection kit (Southern Light; Tropix, Bedford, MA)
and X-ray film.
Quantification of calbindin protein and mRNA.
Slot immunoblots and autoradiographed films from mRNA slot-blots were analyzed using scanning densitometry (Molecular Dynamics, Sunnyvale, CA). Quantification of calbindin-D28k protein was reported as densitometry units and mRNA as the ratio of densitometry units of calbindin-D28k mRNA:ß-actin mRNA.
Statistical analysis.
Data are reported as means ± SD. Means for weight gain, serum calcium and inorganic phosphorous were compared using one-way analysis of variance followed by the Waller-Duncan K-ratio t test (SAS Institute, Cary, NC). Values for calbindin protein and the ratio of calbindin mRNA:B-actin mRNA were analyzed by two-way analysis of variance and the means compared using the Waller-Duncan K-ratio t test (SAS Institute). A value of P < 0.05 was considered significant.
| RESULTS |
|---|
|
|
|---|
Adding aluminum to either control or low calcium diets significantly
reduced body weight gain relative to chicks fed the same diets without
aluminum (Table 2
). In the control plus aluminum group, this seemed to be due in large
part to reduced food intake relative to the control group. In the low
calcium plus aluminum group, the reduced weight gain relative to the
low Ca group seemed to result from the inability to use food for weight
gain rather than a reduction in food intake. Reduced feed efficiency
seemed even more pronounced in the vitamin D-free group.
|
Chicks fed a low calcium diet had significantly lower serum calcium
concentrations than did controls, but serum inorganic phosphorus was
unaffected (Table 3
). Adding aluminum to the low calcium diet did not alter the already low
serum calcium concentrations and did not significantly affect serum
phosphorus levels. Aluminum in the control diet, however, caused small
but significant decreases in both serum calcium and inorganic
phosphorus levels relative to controls.
|
The effect of dietary treatments on calbindin protein concentrations in
the intestine are demonstrated visually in a representative Western
blot (Fig. 1
). The lack of a calbindin band in the vitamin D-free group and the
increase in band density in the low calcium group relative to the
control validate the specificity of the antibody for calbindin-D28k
protein and the ability of the assay to detect physiological changes in
calbindin concentrations. Also apparent is that dietary aluminum
greatly inhibited the upregulation of calbindin concentrations by low
calcium intakes. To quantify the changes in calbindin protein with
dietary treatment, slot immunoblots performed on five samples from each
group were analyzed by scanning densitometry, and the means were
compared (Fig. 2
black bars). There was significantly more (
40%) calbindin protein
in the low calcium group relative to controls. In the low calcium plus
aluminum group, however, calbindin protein levels did not differ from
the controls. Surprisingly, calbindin protein was greater in the
control plus aluminum group than in the control group.
|
|
Specificity of the oligonucleotide used as a probe for calbindin-D28k
mRNA is demonstrated in the Northern blot shown in Figure 3
. Two bands were visible (indicated by arrows) representing the
predominant 2.0-kb and 2.8-kb species of calbindin-D28k mRNA
(26
,27)
. Specificity was established by the lack of signal
in the vitamin D-free group (negative control). Increasing the
amount of mRNA used on the blot from 5 to 7 µg produced a
corresponding increase in signal intensity, demonstrating that the
assay could detect small changes in calbindin mRNA levels.
|
|
In contrast to the effects seen with a low calcium diet, when chicks
consumed aluminum in the control diet, calbindin mRNA levels were not
different than in controls (Fig. 2)
. Yet, there were reductions in both
serum calcium and phosphorus in this group (Table 3)
, suggesting that
mRNA levels should have increased. These findings indicate that
aluminum inhibited the upregulation of calbindin mRNA in the control
diet as well. It is interesting that aluminum increased calbindin
protein in this group relative to the controls, even though mRNA levels
were unaffected.
| DISCUSSION |
|---|
|
|
|---|
The mechanism(s) by which aluminum interferes with calbindin mRNA
expression was not resolved by this study. At present, we can say that
reduced expression was not due to aluminum-induced changes in serum
calcium or phosphorous levels, because these were the same in the low
calcium and low calcium plus aluminum groups. Aluminum could have
inhibited expression by causing reductions in serum levels of
1,25(OH)2D because previous studies have
indicated that aluminum may decrease renal conversion of vitamin D to
1,25(OH)2D (23)
. In that study and
others, however, it was also shown that aluminum inhibits the ability
of physiological injections of 1,25(OH)2D to
increase calbindin concentrations in the intestine
(11
,20
,23)
. Therefore, aluminum inhibited calbindin
expression even in the presence of physiological levels of the active
hormone. This finding indicates that aluminum directly interferes with
the ability of the intestinal cell to respond to
1,25(OH)2D. Our results suggest that this
inability to respond is due to inhibition of vitamin
D-dependent transcription of the calbindin gene and/or a
decrease in the stability of calbindin mRNA.
In bone, aluminum toxicity also causes decreased responsiveness to the
active form of vitamin D, but the mechanism seems to differ from that
in the intestine. Studies in cultured rat ostoblast-like
osteosarcoma cells have shown that the ability of
1,25(OH)2D to stimulate osteocalcin synthesis is
inhibited by aluminum (15
,16)
. Although the mechanism is
not fully understood, Fanti et al. (16)
showed that
osteocalcin mRNA expression in these cells was not affected. They
concluded that aluminum did not decrease the transcription or stability
of the mRNA but rather, it had a direct posttranscriptional effect on
osteocalcin production. Because osteocalcin protein degradation was not
affected, they suggested that aluminum altered some aspect of
osteocalcin synthesis, such as mRNA translation or processing of the
synthesized protein. These findings differ from our results, showing
decreased calbindin mRNA levels, and indicate that aluminum affects the
expression of calbindin and osteocalcin at different biochemical sites.
This argues against a common effect of aluminum on the fundamental
genomic actions of vitamin D across tissues.
There are several possibilities for how aluminum could affect the
expression of different vitamin D-dependent genes by
different mechanisms. Tissue-specific aspects of aluminum
metabolism, such as the concentration and/or species of aluminum in
different cell types, could result in different sites of action. The
level of vitamin D exposure under different experimental conditions
could be a factor, because high concentrations of
1,25(OH)2D are protective against some actions of
aluminum (15)
. It is also possible that the different
molecular aspects of the transcriptional and translational events that
occur during the expression of calbindin versus osteocalcin could have
different susceptibilities to the action of aluminum. It is conceivable
then, that calbindin-D28k is affected at the level of mRNA expression,
but that osteocalcin is affected posttranscriptionally.
Our own data suggest that the expression of calbindin is affected
posttranscriptionally as well, but the effect seems to be stimulatory.
A posttranscriptional effect was most evident in the control plus
aluminum group, where relative to controls, calbindin protein was
increased, but calbindin mRNA was not. This finding suggests that
aluminum either increased the translation of calbindin mRNA and, hence,
calbindin synthesis or that it stabilized the calbindin protein and
reduced its rate of degradation. This hypothesis is supported by
the greater ratio of calbindin protein to calbindin mRNA in both groups
exposed to aluminum relative to their respective controls (Fig. 2)
.
Potential mechanisms for posttranscriptional effects of aluminum are
only hypothetical at present. There is evidence that aluminum binds to
nucleic acids and calcium-binding proteins (9
,30)
, but
little is known about how this may alter their function or turnover.
There is also evidence that 1,25(OH)2D and
calcium can upregulate posttranscriptional steps in calbindin
production (18)
, but the mechanisms are unclear and no
studies have been performed to determine whether aluminum can influence
this regulation. It is possible that the decrease in serum calcium and
phosphorous induced by aluminum intake in the control group stimulated
calbindin synthesis without a corresponding increase in calbindin mRNA.
Whatever the mechanism, the net effect of aluminum on the concentration
of calbindin in the intestine seems to depend on the relative effects
of this metal on decreasing mRNA expression versus stimulating
calbindin production. Apparently the inhibitory effect on mRNA
expression was dominant in the low calcium diets, but not in the
control diets.
The reason for the different effects of aluminum depending on the
concentration of calcium in the diet is not clear. It may be related to
a lower concentration of aluminum in the intestinal cell in chicks fed
the control diet because calcium has been shown to inhibit mucosal
uptake of aluminum (31)
. Diets adequate in calcium, then,
may be protective against the inhibitory effects of aluminum on
calbindin mRNA expression.
We have shown that high intakes of aluminum can inhibit the expression of calbindin mRNA, thus, inhibiting the intestinal adaptation to low calcium diets mediated by 1,25(OH)2D. The mechanism for this effect is not fully understood. Comparisons with studies on osteocalcin expression indicate that aluminum may not universally inhibit a fundamental step in the genomic regulation of vitamin D-dependent genes. Rather, aluminum can affect multiple sites in the transcriptional and posttranscriptional control of protein expression depending on the tissue involved, the calcium content of the diet and possibly other dietary and physiological factors.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
2 Supported in part by Grant 95-372000-1627 from the U.S. Department of Agriculture, National Research Initiative
Competitive Grants Program. ![]()
4 Abbreviations used: 1,25(OH)2D, 1,25-dihydroxycholecalciferol; TBS, Tris-buffered saline; TTBS, TBS
plus Tween 20; SSC, standard saline citrate; FITC, fluorescein isothiocyanate. ![]()
Manuscript received November 22, 2000. Initial review completed December 22, 2000. Revision accepted March 27, 2001.
| REFERENCES |
|---|
|
|
|---|
1. Greger J. L., Sutherland J. E. Aluminum exposure and metabolism. Crit. Rev. Clin. Lab. Sci. 1997;34:439-474[Medline]
2. Flaten T. P., Alfrey A. C., Birchall J. D., Savory J., Yokel R. A. Status and future concerns of clinical and environmental aluminum toxicology. J. Toxicol. Environ. Health 1996;48:527-541[Medline]
3.
Bishop N. J., Morley R., Chir B., Day J. P., Lucas A. Aluminum neurotoxicity in preterm infants receiving intravenous-feeding solutions. N. Engl. J. Med. 1997;337:1557-1561
4. Bougle D., Sabatier J. P., Bureau F., Laroche D., Brouard J., Guillois B., Duhamel J. F. Relationship between bone mineralization and aluminum in the healthy infant. Eur. J. Clin. Nutr. 1998;52:431-435[Medline]
5. Woodson G. C. An interesting case of osteomalcia due to antacid use associated with stainable bone aluminum in a patient with normal renal function. Bone 1998;22:695-698[Medline]
6. Gilbert-Barness E., Barness L. Aluminum toxicity. Arch. Pediatr. Adolesc. Med. 1998;15:511-512
7. Jeffery E. H., Abreo K., Burgess E., Canmata J., Greger J. L. Systemic aluminum toxicity: effects on bone, hematopoietic tissue and kidney. J. Toxicol. Environ. Health 1996;48:649-665[Medline]
8. Exley C. A molecular mechanism of aluminum-induced Alzheimers disease?. J. Inorg. Biochem. 1999;76:133-140[Medline]
9. Lukiw W. J., LeBlanc H. J., Carver L. A., McLachlan D. R. C., Bazan N. G. Run-on gene transcription in human neocortical nuclei. J. Mol. Neurosci. 1998;11:67-78[Medline]
10. Dunn M. A., Johnson N. E., Liew M. Y. B., Ross E. Dietary aluminum chloride reduces the amount of intestinal calbindin-D28k in chicks fed low calcium or low phosphorus diets. J. Nutr. 1993;123:1786-1793
11. Dunn M. A., Ishizakie A. S., Liew M. Y. B., Too S. L., Johnson N. Dietary aluminum chloride inhibits the ability of vitamin D to regulate intestinal calbindin-D28k levels in chicks. J. Trace Elem. Exper. Med. 1995;8:47-57
12. Goodman W. G., Duarte M. E. L. Aluminum: effects on bone and role in the pathogenesis of renal osteodystrophy. Miner. Electrolyte Metab. 1991;17:221-232[Medline]
13. Lian J. B., Stein G. S., Stein J. L., Van Wijnen A. J. Regulated expression of the bone-specific osteocalcin gene by vitamins and hormones. Vitam. Horm. 1999;55:443-509[Medline]
14. Mosavin R., Mellon W. S. Post-transcriptional regulation of osteocalcin mRNA in clonal osteoblast cells by 1,25-dihydroxyvitamin D3. Arch. Biochem. Biophys. 1996;332:142-152[Medline]
15. Lajeunesse D., Moreau R., Hobbs W., Qui W., Lafond J., Guggino S. E. Influence of aluminum on the regulation of PTH and 1,25(OH)2D3-dependent pathways in the rat osteosarcoma cell line ROS 17/28. J. Bone Miner. Res. 1998;13:962-969[Medline]
16. Fanti P., Kindy M. S., Mohapatra S., Klein J., Columbo G., Malluche H. H. Dose-dependent effects of aluminum on osteocalcin synthesis in osteoblast like ROS 17/2 cells in culture. Am. J. Physiol. 1992;263:E1113-E1118
17. Bronner F. Current concepts of calcium absorption: an overview. J. Nutr. 1992;122:641-643
18. Duflos C., Bellaton C., Baghdassarian N., Gadoux M., Pansu D., Bronner F. 1,25-dihydroxycholecalciferol regulates rat intestinal calbindin-D9k post-transcriptionally. J. Nutr. 1996;126:834-841
19. Meyer J., Galligan M. A., Jones G., Komm B. S., Haussler C. A., Haussler M. R. 1,25(OH)2D3-Dependent regulation of calbindin-D28k mRNA requires ongoing protein synthesis in chick duodenal organ culture. J. Cell. Biochem. 1995;58:315-327[Medline]
20. Orihuela D., Favre C., Monti J. A., Carnovale C. E., Carrillo M. C. Aluminum effects upon calbindin D9k-linked duodenal calcium transport in diabetic male rats. Toxicol. Lett. 1999;104:211-219[Medline]
21. Meyer J., Fullmer C. S., Wasserman R. H., Komm B. S., Haussler M. R. Dietary restriction of calcium, phosphorous, and vitamin D elicits differential regulation of the mRNAs for avian intestinal calbindin-D28k and the 1,25-dihydroxyvitamin D3 receptor. J. Bone Miner. Res. 1992;7:441-448[Medline]
22.
Adler A. J., Zara C., Berlyne G. M. Effect of aluminum on bidirectional calcium flux in rat everted intestinal sacs. Am. J. Physiol. 1989;257:G433-G437
23. Henry H. L., Norman A. W. Interactions between aluminum and the actions and metabolism of vitamin D3 in the chick. Calcif. Tissue Int. 1985;37:484-490[Medline]
24. Blahos J., Care A. D., Abbas S. K., Corlette S. C. Aluminum-induced decrease in osteocalcin levels in the chick. Horm. Metab. Res. 1991;23:50-51[Medline]
25. National Research Council Nutrient Requirements of Poultry 9th revised ed 1994:81 National Academy Press Washington, D.C.
26.
Clemens T. L., McGlade S. A., Garrett K. P., Horiuchi N., Hendy G. N. Tissue-specific regulation of avian vitamin D-dependent calcium binding protein 28kDa mRNA by 1,25-dihydroxyvitamin D3. J. Biol. Chem. 1998;263:13112-13116
27.
Huang Y. C., Christakos S. Modulation of rat calbindin-D28k gene expression by 1,25-dihydroxyvitamin D3 and dietary alteration. Mol. Endocrinol. 1988;2:928-935
28. Merke J., Lucas P. A., Szabo A., Helbing F., Hugel U., Drueke T., Ritz E. 1,25(OH)2D3 Receptors and end organ response in experimental aluminum intoxication. Kidney Int 1987;32:204-211[Medline]
29.
Sooy K., Schermerhorn T., Noda M., Surana M., Rhoten W. B., Meyer M., Fleischer N., Sharp G.W.G., Christakos S. Calbindin-D28k controls [Ca2+]I and insulin release. J. Biol. Chem. 1999;274:34343-34349
30. Adler A. J., Caruso C., Berlyne G. M. Effect of aluminum on calcium-binding to bovine intestinal calcium-binding protein. Miner. Elect. Metab. 1991;17:141-146[Medline]
31. van der Voet G. B., de Wolff F. A. Intestinal absorption of aluminum: effect of sodium and calcium. Arch. Toxicol. 1998;72:110-114[Medline]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||